Clinical Considerations Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults

Centers for Disease Control and Prevention. (2021). Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults. U.S. Department of Health and Human Services.
This resource page provides recommendations for clinicians related to reports of myocarditis and pericarditis in adolescents and young adults following mRNA COVID-19 vaccination.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.